AMS Biotechnology (AMSBIO) is now recognised as a leading company contributing to the acceleration of discovery by providing advanced life science technology products and services for research and development. It is a global provider of customised research products and services for biological and pharmaceutical research.
Founded in 1987, AMS Biotechnology (AMSBIO) provides specialised antibodies, peptides and recombinant proteins. In addition, the company can draw on its deep expertise in extracellular matrices to provide elegant solutions for the study of cell motility, migration, invasion and proliferation. Widely recognised as a cell culture expert, AMSBIO collaborates with customers to tailor cell systems to improve screening results and eventual prognosis. With a range of molecular detection reagents and a large biological repository, the company can also supply DNA, RNA, protein and tissue microarray products. The main research areas for these products are: Oncology, regenerative medicine, environmental analysis, cytotoxicity screening, glycomics and stem cell biology.
AMSBIO’s mission is to be the leading cost-effective provider of quality reagents and services for life science research, helping customers develop innovative methods, processes, products and medicines. This is achieved by offering small and medium-sized manufacturers, academic groups and revenue-generating biotechs a unique partnership for the global market and providing cutting-edge, cost-effective solutions to end-users and partners.
AMSBIO has made a new strategic investment to enhance the level of support to its large and growing customer base across the European Union.
AMSBIO has opened a new office in Alkmaar, the Netherlands. The new AMSBIO Europe BV office already offers EU customers quick and easy access to the company’s wide range of high quality products and consumables.
